Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model
Open Access
- 31 March 2016
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 8 (1) , 1-15
Abstract
Epigenetic regulation has emerged to be the critical steps for tumorigenesis and metastasis. Multiple histone methyltransferase and demethylase have been implicated as tumor suppressors or oncogenes recently. But the key epigenomic events in cancer cell transformation still remain poorly understood. A breast cancer transformation model was established via stably expressing three oncogenes in primary breast epithelial cells. Chromatin immunoprecipitation followed by the next-generation sequencing of histone methylations was performed to determine epigenetic events during transformation. Western blot, quantitative RT-PCR, and immunostaining were used to determine gene expression in cells and tissues. Histones H3K9me2 and me3, two repressive marks of transcription, decrease in in vitro breast cancer cell model and in vivo clinical tissues. A survey of enzymes related with H3K9 methylation indicated that KDM3A/JMJD1A, a demethylase for H3K9me1 and me2, gradually increases during cancer transformation and is elevated in patient tissues. KDM3A/JMJD1A deficiency impairs the growth of tumors in nude mice and transformed cell lines. Genome-wide ChIP-seq analysis reveals that the boundaries of decreased H3K9me2 large organized chromatin K9 modifications (LOCKs) are enriched with cancer-related genes, such as MYC and PAX3. Further studies show that KDM3A/JMJD1A directly binds to these oncogenes and regulates their transcription by removing H3K9me2 mark. Our study demonstrates reduction of histones H3K9 me2 and me3, and elevation of KDM3A/JMJD1A as important events for breast cancer, and illustrates the dynamic epigenomic mechanisms during breast cancer transformation.Keywords
Funding Information
- National Basic Research Program of China (2011CB504206, 2012CB518700)
- National Natural Science Foundation of China (31221061, 31200653, 31370866)
This publication has 47 references indexed in Scilit:
- The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancerNucleic Acids Research, 2014
- Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancerBritish Journal of Cancer, 2014
- SET for life: biochemical activities and biological functions of SET domain-containing proteinsTrends in Biochemical Sciences, 2013
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomasActa Neuropathologica, 2013
- Global Levels of Histone Modifications Predict Prognosis in Different CancersThe American Journal of Pathology, 2009
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient OutcomeCancer Research, 2009
- Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cellsNature Genetics, 2009
- Reflecting on 25 years with MYCNature Reviews Cancer, 2008
- Global histone modification patterns predict risk of prostate cancer recurrenceNature, 2005
- Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cellsGenes & Development, 2001